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Abstract
Since the cloning of the first human RECQ gene, RECQ1, more than 15 years ago, RECQ helicases
have been a major focus in cancer research. Recent studies of human RECQ protein complexes are
providing insight into their roles in various DNA metabolic pathways that protect the integrity of
our genome.
Introduction and context
The highly conserved RecQ helicase was first identified
in Escherichia coli about 25 years ago and was subse-
quently found to be required for suppressing illegitimate
recombination in both E. coli and yeast [1-3]. Ten years
later, discovery of the link between the human homolog,
BLM, and Bloom syndrome demonstrated the impor-
tance of the RecQ family helicases in human health [4].
Bloom syndrome is a devastating genetic disorder that
causes cancer predisposition. Cells derived from Bloom
syndrome patients show high levels of sister chromatid
exchange resulting from DNA recombination and
genome rearrangements reminiscent of those found in
lower organisms [5].
Importantly, BLM is not the only RECQ homolog to be
identified in humans. During evolution, the RecQ gene
has been amplified and has diverged from a single copy
in bacteria to five RECQ homologs in humans, namely,
RECQ1, BLM, WRN, RECQ4, and RECQ5. Importantly,
although there are multiple REC helicases in humans,
they are not redundant, as mutations in different RECQ
helicases are responsible for distinct clinical diseases [6].
Bloom syndrome, Werner syndrome, and Rothmund-
Thomson syndrome have been linked to defects in BLM,
WRN, and RECQ4, respectively. In the past decade, much
research has been dedicated to uncovering molecular
functions of RECQ family helicases linked with different
clinical disorders.
Major recent advances
Among the five human RECQ helicases, BLM has been
the most extensively studied. BLM is found in a complex
with topoisomerase IIIa (TOPOIIIa) and the RecQ-
mediated genome instability (RMI) proteins RMI1 and
RMI2. Cumulative data indicate that BLM makes use of
four possible mechanisms to repair DNA breaks by both
promoting and suppressing homologous recombination
(Figure 1) [7]. First, BLM, together with TOPOIIIa and
RMI1/2, dissolves double Holliday junction intermedi-
ates into non-crossover products [8]. Second, BLM may
contribute to the synthesis-dependent single-stranded
annealing pathway, leading exclusively to products
without sister chromatid exchange [9]. Most recently,
BLM has been implicated in two opposite roles:
disassembling the RAD51 filament from the break site
to prevent homologous recombination; and facilitating
end resection to promote homologous recombination
[10-12].
While it is clear that BLM is an essential player in
safeguardingtheprogressionandinfluencingtheoutcome
ofhomologousrecombinationevents,howthesepro-and
anti-recombinational rolesofBLM are coordinated during
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complicating the story, it had been thought that elevated
levels of sister chromatid exchange accompanied by
chromosome rearrangement are a hallmark of Bloom
syndromecellsandakeyfeatureintheclinicaldiagnosisof
Bloom syndrome, however, recent studies have shown
that mouse embryonic stem cells defective in RECQ5
exhibit a phenotype similar to that of Bloom syndrome
cells [13]. Furthermore, even though RECQ5 mutations
are not linked to Bloom syndrome or any other clinical
disease in humans, RECQ5 deletion in mice results in a
significant increase in the development of solid tumors in
various organs such as the lung, liver, and breast [14].
Notably, the recq5-/- blm-/- double mutant exhibited an
even greater frequency of sister chromatid exchange than
either of the single mutants, suggesting that these two
proteins contribute to regulation of sister chromatid
exchange via different mechanisms [13].















A recombination event is initiated by a DNA break and leads to crossover or non-crossover products. First, the DNA ends are resected to produce
single-stranded DNA, which in a reaction catalyzed by RAD51 recombinase can then invade the homologous duplex DNA to form a recombination
intermediate, or D-loop structure. After homologous recombination is initiated by RAD51 at one end of the broken DNA, the second DNA end may
be captured by the unpaired strand of the homologous DNA. The resulting recombination intermediate can proceed to form double Holliday junctions (HJs),
and any remaining gaps may be filled by DNA synthesis. HJs can be cleaved by HJ resolvase (center right) or dissociated by the BLM-dependent pathway
(center left). In mitotic cells, it is argued that the majority of homologous recombination is completed without the formation of HJs. Instead, most homologous
recombination events are completed by synthesis-dependent strand annealing (SDSA) to generate non-crossover products that result from dissociation
of the D-loop after DNA synthesis (left). The newly synthesized DNA is available to re-anneal with the second end of the same DNA molecule at the
break site. DNA synthesis continues to fill the gap and restore the integrity of the DNA without crossover. Alternatively, D-loop structure can be cleaved
to generate sister chromatid exchange (SCE) products (right). Possible points of RECQ5 action discussed in the text are indicated by (1), (2), and (3).
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junctions [15], it is possible that it may function to
promote synthesis-dependent single-strand annealing
(Figure 1, mechanism 1). Alternatively, it has been
shown that RECQ5 has an antagonistic role in prevent-
ing RAD51 filament formation (Figure 1, mechanism 2)
[14]. However, both of these RAD51-dependent
mechanisms are redundant to BLM function and are
not likely to represent the primary role of RECQ5 in
suppressing sister chromatid exchanges. Indeed, a recent
report demonstrated an additive sensitivity to camp-
tothecin treatment in recq5-rad51 double mutants [16],
arguing for a role of RECQ5 in a RAD51-independent
pathway.
A recent surprise in the field came with the purification
from human cells of a multiprotein complex containing
the RECQ5 helicase. Unlike BLM, which forms a stable
complex with TOPOIIIa and RMI1/2 to function as a
‘dissolvasome’ in homologous recombination [7],
RECQ5 primarily interacts with RNA polymerase II, the
enzyme responsible for messenger RNA synthesis in
eukaryotes (Figure 2) [17,18]. Importantly, this interac-
tion is specific to RECQ5 but not to other RECQ
helicases [17]. Further biochemical analysis revealed
that RECQ5 efficiently suppresses RNA polymerase II-
dependent transcription via direct protein-protein inter-




are clearly consistent with a role in homologous
recombination pathways leading exclusively to formation
of non-sister chromatid exchange products (Figure 1).
On the other hand, many questions remain regarding the
physiological connection between the RECQ5-RNA poly-
merase II interaction and sister chromatid exchange.
Nonetheless, the potential link between transcription
and recombination may not be unexpected. While
transcription is essential for cells to function and grow,
the process itself can generate undesirable DNA lesions
andresultingenomeinstability[20].Indeed,mutationsin
RNA processing factors, such as ASF/SF2 and THO/TREX,
result in double-stranded break formation and transcrip-
tion-associated recombination [21,22]. It is very reason-
able, therefore, to expect that RECQ5 could have a unique
function in preventing DNA break formation during
transcription (Figure 1, mechanism 3). According to this
hypothesis, transcription-dependent double-stranded
breaks would be generated in the absence of RECQ5 and
subsequently repaired by homologous recombination,
leading to an increase in sister chromatid exchange. It is
worth noting that transcription-associated recombination
was also observed in yeast [20], yet Sgs1, the only RecQ
homolog in yeast, has not been implicated in this process.
Further, Sgs1 is not known to interact with RNA
polymerase II. Thus, it is possible that a role for RECQ-
like helicases in transcription-associated recombination
has been acquired during the course of evolution and is
unique to higher eukaryotes.
Given that the key to solving the puzzle regarding
RECQ5 and BLM may lie within the distinct protein
complexes they form in cells, the identification of other
RECQ helicase complexes may provide important clues
to the unique functions of the remaining RECQ helicases
in DNA metabolism. Such discoveries would allow us to
start to understand how the human RECQ helicases
associate with different clinical syndromes that have
specific cancer spectra.
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